fbpx
close read more
Videos

Parkinson’s disease: Servier, a committed stakeholder

11/04/2022

Parkinson’s disease: Servier, a committed stakeholder

Committed to neuroscience, Servier is focusing its research efforts on the discovery of drug candidates that slow the progression of Parkinson’s disease, as well as clinically-related diseases. Discover the Group’s commitment in video.  

Latest brochures and media

Brochures
25/05/2022
Brochures on the symptoms and treatment of depression
Videos
31/03/2022
Partnership Servier / Celsius Therapeutics
Websites & Apps